肺动脉高压大鼠肺组织中TGFβ1和IL6的表达水平及意义(4)
[7]王丹姝,方蓮花,杜冠华转化生长因子β1在肺动脉高压中作用的研究进展中国药理学通报,2017,33(6):741744
[8]雷丰丰,张启菎,万毅新。转化生长因子β1与肺纤维化新医学,2003,34(11):715716
[9]Li XW, Du J, Hu GY, Hu CP, Li D, Li YJ, Li XH Fluorofenidone attenuates vascular remodeling in hypoxiainduced pulmonary hypertension of ratsCan J Physiol Pharmacol,2014,92(1):5869
[10]Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West JInteraction of interleukin6 and the BMP pathway in pulmonary smooth muscleAm J Physiol Lung Cell Mol Physiol,2007,292(6):L1473L1479
[11]HashimotoKataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, Minami M, Inagaki T, Miyagawa S, Sawa Y, Murakami M, Kumanogoh A, YamauchiTakihara K, Okumura M, Kishimoto T, Komuro I, Shirai M, Sakata Y, Nakaoka YInterleukin6/interleukin21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertensionProc Natl Acad Sci U S A,2015,112(20):E2677E2686
[12]Humbert M, Monti G, Brenot F, Sitbon O, Portier A, GrangeotKeros L, Duroux P, Galanaud P, Simonneau G, Emilie DIncreased interleukin1 and interleukin6 serum concentrations in severe primary pulmonary hypertensionAm J Respir Crit Care Med,1995,151(5):16281631(邓凯 邹勇 廖志新 郑常龙)
鐎甸偊鍠曟穱濠囧棘閸モ晝褰�
闁稿繗娅曢弫鐐烘儌閻愵剙顎�
閻犲洤瀚鎴﹀礄閻樻彃缍�
闁瑰吋绮庨崒銊╁即閺夋埈妯�
|